Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
5.35
-0.10 (-1.83%)
May 5, 2026, 4:00 PM EDT - Market closed
Aptevo Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $199,800 → $106,560 | Strong Buy | Maintains | $199,800 → $106,560 | +1,991,675.70% | Sep 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $40,439,520 → $11,721,600 | Buy | Maintains | $40,439,520 → $11,721,600 | +219,095,227.10% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $37,509,120 → $29,304,000 | Strong Buy | Maintains | $37,509,120 → $29,304,000 | +547,738,217.76% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $18,754,560 → $40,439,520 | Buy | Maintains | $18,754,560 → $40,439,520 | +755,878,778.50% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $98,461,440 | Strong Buy | Initiates | $98,461,440 | +1,840,400,647.66% | Apr 11, 2018 |
| Piper Sandler | Piper Sandler | Buy Initiates $57,435,840 | Buy | Initiates | $57,435,840 | +1,073,567,002.80% | Sep 9, 2016 |